CD19-directed chimeric antigen receptor T cell compositions and methods and uses thereof

Provided in some aspects are compositions of cells for treating subjects with disease and conditions such as non-Hodgkin's lymphoma (NHL), and related methods, compositions, uses and articles of manufacture. In some embodiments, the disease or condition is a B-cell non-Hodgkin lymphoma (B-cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BRIGGS, Adrian Wrangham, CHAN, Calvin, WESTOBY, Matthew, BASHOUR, Keenan, HEGE, Kristen, GERMEROTH, Lothar, SALMON, Ruth Amanda, VARUN, Divya, WU, Kaida, KUGLER, David G, POLTORAK, Mateusz Pawel, KILAVUZ, Nurgul, BATUREVYCH, Oleksandr, CASPARY, Robert Guy, BURGESS, Michael, STEMBERGER, Christian
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided in some aspects are compositions of cells for treating subjects with disease and conditions such as non-Hodgkin's lymphoma (NHL), and related methods, compositions, uses and articles of manufacture. In some embodiments, the disease or condition is a B-cell non-Hodgkin lymphoma (B-cell NHL). The cells generally express recombinant receptors such as chimeric antigen receptors (CARs) for targeting an antigen, such as CD 19, on cells of the lymphoma.